Rhodopsin Gene Correction and Gene Knockout in Rod Cells
视杆细胞中的视紫红质基因校正和基因敲除
基本信息
- 批准号:7186678
- 负责人:
- 金额:$ 36.41万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1997
- 资助国家:美国
- 起止时间:1997-03-01 至 2011-02-28
- 项目状态:已结题
- 来源:
- 关键词:AnimalsBiological AssayCell physiologyCellsCleaved cellCountDNADNA DamageDefectDependovirusDetectionDiseaseDouble Strand Break RepairEffectivenessEventExonsEye diseasesFluorescenceFoundationsFrequenciesGene ExpressionGene TargetingGenesGenomeGenomicsGoalsGrantGreen Fluorescent ProteinsHumanIndividualIntronsKnock-in MouseKnock-outLeadLocalizedMeasuresMessenger RNAMetabolismMethodsMusMutateMutationNeurodegenerative DisordersNeuronsNonsense-Mediated DecayOcular PhysiologyPhotoreceptorsPoisonProceduresProcessPropertyProteinsRangeReagentResearch PersonnelRetinaRetinal DegenerationRetinitis PigmentosaRhodopsinRod Outer SegmentsSiteStructureSystemTestingTherapeuticZinc Fingersadeno-associated viral vectorbasedesignfusion genegene correctiongene repairgenetic manipulationhomologous recombinationknockout genemouse genomemutantnovelnucleaseprogramsrepairedresearch studyretinal rodssubretinal injectiontherapy design
项目摘要
DESCRIPTION (provided by applicant): Strategies for correction and knockout of the rhodopsin gene in rod photoreceptor cells will be tested to determine what it takes to manipulate the structure and expression of deleterious genes in terminally differentiated neurons. We seek to understand the fundamental cellular processes that allow targeted gene repair and mutation in these cells, as well as those that can control expression of toxic proteins. In the process of gaining this understanding, we aim to develop effective methods for treating autosomal dominant retinitis pigmentosa (ADRP) caused by defects in the rhodopsin gene. Successful therapies for ADRP will provide a paradigm for treatment of dominant eye diseases and other neurodegenerative disorders. Mice are a natural choice for these studies because their eye physiology resembles that of humans; ADRP disease genes cause retinal degeneration in mice more quickly than in humans and large animals, allowing rapid testing of efficacy; and mouse genomes can be readily manipulated. Previously, we fused the complete human rhodopsin gene-the ultimate target for therapy-to the GFP gene to generate a visible marker for rhodopsin expression that localizes properly to rod outer segments. Here, we propose to use our existing wild type rhodopsin-GTP mice and generate four new mouse lines carrying mutant human rhodopsin-GFP genes to provide targets for various kinds of genetic manipulation. These modified human rhodopsin-GFP genes will include three defined ADRP mutations-P23H, Q64ter, and Q344ter-and a gene that carries an internal duplication. Adeno-associated virus vectors will be used to deliver novel reagents for rhodopsin correction and knockout. For gene correction, we will test segments of rhodopsin DNA in the presence and absence of genes for zinc-finger nucleases (ZFNs) that have been rationally designed to cleave near the target mutations. For gene knockout, we will test exon-specific ZFNs to mutate the rhodopsin-GFP gene directly, and intron- specific ZFNs designed to stimulate incorporation of a 'killer' exon that will poison expression of the rhodopsin gene. Assays for rhodopsin gene correction and knockout will utilize the fluorescent properties of the human rhodopsin-GFP target gene.
描述(申请人提供):将测试纠正和敲除视紫红质基因的策略,以确定在终末分化的神经元中操纵有害基因的结构和表达所需的条件。我们试图了解在这些细胞中允许有针对性的基因修复和突变的基本细胞过程,以及那些可以控制有毒蛋白质表达的过程。在获得这一认识的过程中,我们的目标是开发有效的方法来治疗由视紫红质基因缺陷引起的常染色体显性遗传性视网膜色素变性(ADRP)。ADRP的成功治疗将为治疗显性眼病和其他神经退行性疾病提供一个范例。老鼠是这些研究的自然选择,因为它们的眼睛生理与人类相似;adrp疾病基因在老鼠身上导致视网膜退化的速度比人类和大型动物更快,从而能够快速测试疗效;而且老鼠的基因组很容易被操纵。此前,我们将完整的人视紫质基因--治疗的最终目标--与GFP基因融合,生成视紫红质表达的可见标记,该标记正确地定位于视杆外部节段。在这里,我们计划利用我们现有的野生型视紫红质-GTP小鼠,产生四个新的携带突变的人视紫质-GFP基因的小鼠系,为各种遗传操作提供靶点。这些修改后的人类视紫红质-GFP基因将包括三个明确的ADRP突变-P23H、Q64ter和Q344ter-以及一个携带内部复制的基因。腺相关病毒载体将被用来运送用于矫正和敲除视紫红质的新型试剂。对于基因校正,我们将在存在和不存在锌指核酸酶(ZFN)基因的情况下测试视紫红质DNA片段,这些基因被合理地设计为在目标突变附近切割。对于基因敲除,我们将测试外显子特定的ZFN,以直接突变视紫红质-GFP基因,以及内含子特定的ZFN,旨在刺激将毒害视紫红质基因表达的‘杀手’外显子的加入。检测视紫红质基因的校正和敲除将利用人类视紫红质-GFP靶基因的荧光特性。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
JOHN H WILSON其他文献
JOHN H WILSON的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('JOHN H WILSON', 18)}}的其他基金
Instability of Triplet Repeats in Mammalian Cells
哺乳动物细胞中三联体重复的不稳定性
- 批准号:
7904472 - 财政年份:2009
- 资助金额:
$ 36.41万 - 项目类别:
Rhodopsin Gene Correction and Gene Knockout in Rod Cells
视杆细胞中的视紫红质基因校正和基因敲除
- 批准号:
7686532 - 财政年份:1997
- 资助金额:
$ 36.41万 - 项目类别:
Rhodopsin Gene Correction and Gene Knockout in Rod Cells
视杆细胞中的视紫红质基因校正和基因敲除
- 批准号:
8655854 - 财政年份:1997
- 资助金额:
$ 36.41万 - 项目类别:
RHODOSPIN GENE CORRECTION BY OLIGONUCLEOTIDE TARGETING
通过寡核苷酸靶向进行视紫红质基因校正
- 批准号:
6314816 - 财政年份:1997
- 资助金额:
$ 36.41万 - 项目类别:
Rhodopsin Gene Correction and Gene Knockout in Rod Cells
视杆细胞中的视紫红质基因校正和基因敲除
- 批准号:
7386597 - 财政年份:1997
- 资助金额:
$ 36.41万 - 项目类别:
RHODOPSIN GENE CORRECTION BY OLIGONUCLEOTIDE TARGETING
通过寡核苷酸靶向进行视紫红质基因校正
- 批准号:
2020240 - 财政年份:1997
- 资助金额:
$ 36.41万 - 项目类别:
RHODOSPIN GENE CORRECTION BY OLIGONUCLEOTIDE TARGETING
通过寡核苷酸靶向进行视紫红质基因校正
- 批准号:
6041352 - 财政年份:1997
- 资助金额:
$ 36.41万 - 项目类别:
RHODOSPIN GENE CORRECTION BY OLIGONUCLEOTIDE TARGETING
通过寡核苷酸靶向进行视紫红质基因校正
- 批准号:
6635654 - 财政年份:1997
- 资助金额:
$ 36.41万 - 项目类别:
Rhodopsin Gene Correction and Gene Knockout in Rod Cells
视杆细胞中的视紫红质基因校正和基因敲除
- 批准号:
8117905 - 财政年份:1997
- 资助金额:
$ 36.41万 - 项目类别:
Rhodopsin Gene Correction and Gene Knockout in Rod Cells
视杆细胞中的视紫红质基因校正和基因敲除
- 批准号:
8260502 - 财政年份:1997
- 资助金额:
$ 36.41万 - 项目类别:
相似海外基金
Establishment of a new biological assay using Hydra nematocyst deployment
利用水螅刺丝囊部署建立新的生物测定方法
- 批准号:
520728-2017 - 财政年份:2017
- 资助金额:
$ 36.41万 - 项目类别:
University Undergraduate Student Research Awards
POINT-OF-CARE BIOLOGICAL ASSAY FOR DETERMINING TISSUE-SPECIFIC ABSORBED IONIZING RADIATION DOSE (BIODOSIMETER) AFTER RADIOLOGICAL AND NUCLEAR EVENTS.
用于确定放射和核事件后组织特异性吸收电离辐射剂量(生物剂量计)的护理点生物测定。
- 批准号:
10368760 - 财政年份:2017
- 资助金额:
$ 36.41万 - 项目类别:
POINT-OF-CARE BIOLOGICAL ASSAY FOR DETERMINING TISSUE-SPECIFIC ABSORBED IONIZING RADIATION DOSE (BIODOSIMETER) AFTER RADIOLOGICAL AND NUCLEAR EVENTS.
用于确定放射和核事件后组织特异性吸收电离辐射剂量(生物剂量计)的护理点生物测定。
- 批准号:
10669539 - 财政年份:2017
- 资助金额:
$ 36.41万 - 项目类别:
POINT-OF-CARE BIOLOGICAL ASSAY FOR DETERMINING TISSUE-SPECIFIC ABSORBED IONIZING RADIATION DOSE (BIODOSIMETER) AFTER RADIOLOGICAL AND NUCLEAR EVENTS.
用于确定放射和核事件后组织特异性吸收电离辐射剂量(生物剂量计)的护理点生物测定。
- 批准号:
9570142 - 财政年份:2017
- 资助金额:
$ 36.41万 - 项目类别:
POINT-OF-CARE BIOLOGICAL ASSAY FOR DETERMINING TISSUE-SPECIFIC ABSORBED IONIZING RADIATION DOSE (BIODOSIMETER) AFTER RADIOLOGICAL AND NUCLEAR EVENTS.
用于确定放射和核事件后组织特异性吸收电离辐射剂量(生物剂量计)的护理点生物测定。
- 批准号:
9915803 - 财政年份:2017
- 资助金额:
$ 36.41万 - 项目类别:
COVID-19 Supplemental work: POINT-OF-CARE BIOLOGICAL ASSAY FOR DETERMINING TISSUE-SPECIFIC ABSORBED IONIZING RADIATION DOSE (BIODOSIMETER).
COVID-19 补充工作:用于确定组织特异性吸收电离辐射剂量的护理点生物测定(生物剂量计)。
- 批准号:
10259999 - 财政年份:2017
- 资助金额:
$ 36.41万 - 项目类别:
Drug discovery based on a new biological assay system using Yeast knock-out strain collection
基于使用酵母敲除菌株收集的新生物测定系统的药物发现
- 批准号:
21580130 - 财政年份:2009
- 资助金额:
$ 36.41万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Machine learning for automatic gene annotation using high-throughput biological assay data
使用高通量生物测定数据进行自动基因注释的机器学习
- 批准号:
300985-2004 - 财政年份:2005
- 资助金额:
$ 36.41万 - 项目类别:
Postdoctoral Fellowships
Machine learning for automatic gene annotation using high-throughput biological assay data
使用高通量生物测定数据进行自动基因注释的机器学习
- 批准号:
300985-2004 - 财政年份:2004
- 资助金额:
$ 36.41万 - 项目类别:
Postdoctoral Fellowships